European Case Law Identifier: | ECLI:EP:BA:2013:T006110.20131113 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 13 November 2013 | ||||||||
Case number: | T 0061/10 | ||||||||
Application number: | 97950300.0 | ||||||||
IPC class: | A61K 9/00 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | A NITROIMIDAZOLE GEL COMPOSITION | ||||||||
Applicant name: | Galderma S.A. | ||||||||
Opponent name: | Dr.August Wolff GmbH & Co. Arzneimittel | ||||||||
Board: | 3.3.07 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Main request and auxiliary requests 1 and 3, prohibition of reformatio in peius (yes) Auxiliary request 2, inventive step (no) Auxiliary request 4, admission into proceedings (no) |
||||||||
Catchwords: |
In decisions G 1/99, T 1843/09 and T 1979/11 the existence of a causal link between the limiting feature to be deleted and the new situation arising on appeal was a necessary precondition for justifying an exception to the principle of prohibition of reformatio in peius for reasons of equity. As this precondition is not fulfilled in the present case, a departure from the principle of prohibition of reformatio in peius based on analogies with the cases underlying those decisions is not justified. |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t100061eu1.html
Date retrieved: 17 May 2021